The global bowel management systems market size was valued at USD 1.73 billion in 2017. It is likely to expand at a CAGR of 3.3% during the forecast period. Growing geriatric population, coupled with rising awareness regarding bowel management, has been stimulating the growth of the market.
In addition, the introduction of technologically advanced products is poised to escalate the growth of the market. For instance, Stanford University’s Biodesign program, Pelvalon, launched the Eclipse system - an innovative non-surgical treatment that provides instant results for women experiencing loss of bowel control.
According to a report, An Aging World, in 2015, among 7.3 billion population worldwide, a projected 617.1 million or 8.5% were aged 65 or older. In just 15 years, the number of elderly people is likely to increase by more than 60%. Aging has become a substantial risk factor for fecal incontinence. According to the International Foundation for Gastrointestinal Disorders, in women, bowel incontinence occurs in 6.0% of those below age 40 and increases to 15.0% in older women. Furthermore, among men, bowel incontinence occurs in 6.0-10.0% and it increases with age.
According to WHO, life expectancy is now exceeding 80 years in most of the developed countries. In the geriatric population, incontinence is linked with multiple interacting factors, including chronic diseases such as stroke and disease, mobility impairment, and cognitive impairment.
Fecal incontinence significantly affects a patient’s quality of life. Bowel management systems play an important role in improving the lifestyles of people suffering from the disorder and making their condition better.
Based on products, the market has been categorized into colostomy bags, irrigation systems, nerve modulation devices, and others. Colostomy bags accounted for the largest market share in 2017 owing to rising awareness regarding their availability and benefits. In addition, the availability of well-structured reimbursement policies for colostomy products across developed regions is anticipated to propel the market over the forecast period.
Organizations such as the United Ostomy Associations of America, Inc., and Colostomy U.K. are working towards empowering people who have had an ostomy. Furthermore, government bodies in developed regions are launching schemes to provide support to individuals with a stoma by improving access to clinically appropriate and most suitable stoma-related products. These factors are further projected to contribute to the growth of the colostomy bags segment.
Based on patient type, the market has been bifurcated into adult and pediatric. The adult segment was the largest in 2017. It is expected to show significant growth over the forecast period. This growth can be attributed to the high prevalence of fecal incontinence among adults. It is a common condition among adults, affecting around 1 in 12 adults or 18 million people in the U.S. According to BMJ Publishing Group, fecal incontinence is very common and affects around 10.0% of the population.
Furthermore, increasing availability of technologically advanced products is aiding patients in effectively managing fecal incontinence, which in turn is estimated to benefit the growth of the overall bowel management systems market. Furthermore, rising initiatives to develop patient awareness related to the effective treatment of fecal incontinence is further accelerating the growth of this segment.
Based on end use, the market has been segmented into home care and hospitals and ambulatory surgery centers. The home care segment led the market in 2017. It is likely to witness the fastest growth during the forecast period. The dominance of the segment can be attributed to the rising adoption of bowel management products in home care settings.
Furthermore, the introduction of user-friendly products by manufacturers has enabled patients to maintain their independence and improve their quality of life. Technologically advanced products have helped patients to take care of their bowel problems and continue with their everyday routine with ease. These factors have further supplemented the growth in this segment.
North America was the largest regional market in 2017, followed by Europe. The former will continue to dominate the global market until 2025, owing to the presence of significant market players such as 3M and Medtronic. The heightened adoption rate of bowel management systems, coupled with patient awareness, well-established healthcare infrastructure, and high acceptability of advanced products are among the key factors supporting the dominance of the region.
Asia Pacific is projected to witness the fastest growth during the forecast period due to the rising incidence of fecal incontinence coupled with the increasing geriatric population. Furthermore, huge unmet clinical needs and pressing need for better treatment are poised to drive the market.
The key players in the market are Medtronic; Coloplast; 3M; B. Braun; Consure Medical; C.R. Bard; Cogentix Medical; Axonics Modulation Technologies; Aquaflush Medical Limited; ConvaTec; MBH-International A/S; Hollister; Mederi Therapeutics Inc.; Wellspect HealthCare; and Welland Medical limited.
Players are engaged in different marketing strategies such as R&D activities, an increasing number of collaborations, awareness programs, technological advancements, geographic expansion, and the new product launches to increase their market share. For instance, in 2017, BD, a leading medical technology company acquired C.R. Bard with an aim to strengthen their position in the market.
Attribute |
Details |
Base year for estimation |
2017 |
Actual estimates/Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Market representation |
Revenue in USD Million & CAGR from 2018 to 2025 |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Country Scope |
U.S., Canada, U.K., Germany, Japan, China, India, Brazil, Mexico, South Africa |
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the bowel management systems market report based on the product, patient type, end use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Colostomy Bags
Irrigation Systems
Nerve Modulation Devices
Others
Patient Type Outlook (Revenue, USD Million, 2014 - 2025)
Adult
Pediatric
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Home Care
Hospitals and Ambulatory Surgery Centers
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
MEA
South Africa
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.